Vimarsana
Biggest News Aggregation in the World

Page 29 - Stem Cell Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stem Cell Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stem Cell Therapy Today - Breaking & Trending Today

Global Human Embryonic Stem Cell Market Analysis 2024-2034: - Vimarsana News

Global Human Embryonic Stem Cell Market Analysis 2024-2034:

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The

CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval - Vimarsana News

CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval

Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year.

Exiting the 'era of one-size-fits-all healthcare': Where regenerative medicine is headed in orthopedics - Vimarsana News

Exiting the 'era of one-size-fits-all healthcare': Where regenerative medicine is headed in orthopedics

Regenerative medicine has been growing in orthopedics, and there's one important element that can push it forward in the field.

Vertex Pauses Islet Cell Study After Patient Deaths - Vimarsana News

Vertex Pauses Islet Cell Study After Patient Deaths

The deaths are unrelated to the investigational allogeneic stem cell–derived product VX-880, the company says.

LVPEI: LVPEI Secures 20-Year Patent for Corneal Repair Stem Cell Therapy | Hyderabad News - Vimarsana News

LVPEI: LVPEI Secures 20-Year Patent for Corneal Repair Stem Cell Therapy | Hyderabad News

The L V Prasad Eye Institute (LVPEI) has secured a 20-year patent for an innovative cell therapy designed to mend damaged corneas caused by various corneal diseases. This article highlights the potential of the therapy to revolutionize corneal pathology treatment.